1. I/FHV approached Kofibres Limited, a traditional wool merchant, in January 2022 to develop a supply chain process for SWRFP biomaterial IP created in 2021.
FHV's goal was to establish a robust supply chain process for their biomaterial IP.
Kofibres Limited was approached by I/FHV for collaboration.
2. After signing a non-disclosure agreement (NDA) and positive phone calls, Kofibres directors were invited for a face-to-face meeting at SHD Composite Materials Limited in April 2022.
The purpose of the meeting was to discuss a potential collaboration between Kofibres Limited and SHD Composite Materials Limited.
The meeting took place at Sleafield.
3. All parties attending the meeting at SHD, including SHD, LCSP, and Kofibres, were introduced through FHV.
FHV acted as the connecting entity for all involved parties.
4. A few weeks later, LSCP director Ben Bird requested a meeting in London. LSCP was introduced to Kofibres Limited through the NCC in Bristol, and they were bound by an NDA.
Ben Bird, director of LSCP, requested a meeting with Kofibres Limited.
LSCP was introduced to Kofibres by the NCC in Bristol.
5. During the meeting, Mr. Bird informed that all parties intended to infringe the FHV NDA and apply for an Innovate UK grant using FHV's material.
Mr. Bird revealed the intentions of all parties present at the meeting.
The parties planned to infringe upon the NDA and apply for a grant.
6. Following the meeting, I arranged separate conversations with both SHD and Kofibres.
I organized separate discussions with SHD and Kofibres after the meeting with LSCP.
7. The commercial director of SHD clarified that the decision mentioned by Mr. Bird was not accurate and implied that only SHD directors or employees could make such decisions.
The commercial director of SHD denied the decision mentioned by Mr. Bird.
Only SHD directors or employees could make the mentioned decision.
8. During the meeting with Kofibres, no reference was made to Mr. Bird's comments. However, Kofibres' directors proposed forming a spin-off company, named 'Future Humanity Materials Limited,' as an official means for FHV and Kofibres to develop and sell bioreinforcement for composites.
The directors of Kofibres suggested establishing a spin-off company.
The spin-off company, Future Humanity Materials Limited, was created for the collaboration.
9. After the formation of Future Humanity Materials Limited without a legally structured shareholder agreement, I learned that an application was submitted without my approval.
The formation of the company lacked a legally structured agreement.
An application was submitted without my consent.
10. This application ultimately failed.
The application submitted without my approval did not succeed.
11. SHD received advice from the NCC in Bristol and one of its former employees, urging them not to work with Mr. Bird due to the existing NDAs.
SHD was warned by the NCC and a former employee against collaborating with Mr. Bird.
The advice was based on the mutual non-disclosure agreements.
12. SHD and Kofibres apologized via email and assured that they would not work with Mr. Bird in the future.
SHD and Kofibres conveyed their apologies and confirmed their decision to avoid collaboration with Mr. Bird.
The apologies were communicated by email.
13. However, Genady Fedotov of Kofibres sent me a draft application for another smaller grant proposal involving Mr. Bird, excluding SHD.
Genady Fedotov, from Kofibres, shared a draft application for a different grant proposal.
This application excluded SHD but still included Mr. Bird.
(Note: The mind map generated above is a hierarchical outline based on the provided text. It does not summarize the events.)
Wondershare EdrawMind
